Antonia Digklia

2.0k total citations · 1 hit paper
61 papers, 1.1k citations indexed

About

Antonia Digklia is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Antonia Digklia has authored 61 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 26 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Antonia Digklia's work include Sarcoma Diagnosis and Treatment (14 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Antonia Digklia is often cited by papers focused on Sarcoma Diagnosis and Treatment (14 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Antonia Digklia collaborates with scholars based in Switzerland, Greece and Canada. Antonia Digklia's co-authors include Rafael Durán, Alban Denys, Ioannis A. Voutsadakis, Boris Guiu, Naïk Vietti Violi, Jean‐François Knebel, Christophe Aubé, Jean–Pierre Cercueil, Pierre Deltenre and Isabelle Pache and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Antonia Digklia

57 papers receiving 1.1k citations

Hit Papers

Advanced gastric cancer: ... 2016 2026 2019 2022 2016 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonia Digklia Switzerland 13 443 331 293 213 212 61 1.1k
Liliana Montella Italy 23 594 1.3× 436 1.3× 262 0.9× 286 1.3× 204 1.0× 102 1.6k
Maria A. González-Carmona Germany 20 589 1.3× 294 0.9× 249 0.8× 214 1.0× 173 0.8× 79 1.3k
Vlad Herlea Romania 20 424 1.0× 224 0.7× 367 1.3× 389 1.8× 313 1.5× 120 1.2k
Kohei Shigeta Japan 15 590 1.3× 210 0.6× 139 0.5× 260 1.2× 157 0.7× 75 945
Martha Donoghue United States 16 696 1.6× 400 1.2× 247 0.8× 154 0.7× 285 1.3× 27 1.2k
Takahiro Einama Japan 17 503 1.1× 297 0.9× 192 0.7× 237 1.1× 134 0.6× 83 890
Mariko Tsukagoshi Japan 18 467 1.1× 180 0.5× 228 0.8× 288 1.4× 141 0.7× 108 956
Natsuko Okita Japan 20 855 1.9× 518 1.6× 278 0.9× 271 1.3× 135 0.6× 110 1.3k
Mehmet Akce United States 16 847 1.9× 255 0.8× 187 0.6× 275 1.3× 160 0.8× 115 1.2k
Sandra J. Casak United States 18 455 1.0× 215 0.6× 171 0.6× 189 0.9× 107 0.5× 32 1.0k

Countries citing papers authored by Antonia Digklia

Since Specialization
Citations

This map shows the geographic impact of Antonia Digklia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonia Digklia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonia Digklia more than expected).

Fields of papers citing papers by Antonia Digklia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonia Digklia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonia Digklia. The network helps show where Antonia Digklia may publish in the future.

Co-authorship network of co-authors of Antonia Digklia

This figure shows the co-authorship network connecting the top 25 collaborators of Antonia Digklia. A scholar is included among the top collaborators of Antonia Digklia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonia Digklia. Antonia Digklia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hecht, J. Randolph, Elena Garralda, Hong Jae Chon, et al.. (2025). Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinoma. The Oncologist. 30(3). 1 indexed citations
2.
Locatelli, Isabella, Khalil Zaman, Antonia Digklia, et al.. (2024). A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial. PLoS ONE. 19(6). e0304573–e0304573. 3 indexed citations
3.
Cironi, Luisa, Viviane Praz, Rajendran Sanalkumar, et al.. (2024). CIC-DUX4 Chromatin Profiling Reveals New Epigenetic Dependencies and Actionable Therapeutic Targets in CIC-Rearranged Sarcomas. Cancers. 16(2). 457–457. 5 indexed citations
4.
Gnesin, Silvano, Vincent Dunet, Antonia Digklia, et al.. (2023). 99mTc-macroaggregated albumin SPECT/CT predictive dosimetry and dose-response relationship in uveal melanoma liver metastases treated with first-line selective internal radiation therapy. Scientific Reports. 13(1). 13118–13118. 1 indexed citations
5.
Nguyen‐Ngoc, Tu, et al.. (2023). Overview of Pharmacological Therapies for Diffuse Tenosynovial Giant Cell Tumor. SHILAP Revista de lepidopterología. 3(4). 926–937. 1 indexed citations
6.
Riggi, Nicolò, et al.. (2023). Clear cell sarcoma: state-of-the art and perspectives. Expert Review of Anticancer Therapy. 23(3). 235–242. 6 indexed citations
7.
Digklia, Antonia, et al.. (2023). A Review of Ultrasound-Mediated Checkpoint Inhibitor Immunotherapy. Ultrasound in Medicine & Biology. 50(1). 1–7. 2 indexed citations
8.
Digklia, Antonia, et al.. (2023). Optimal Delivery of Follow-Up Care Following Treatment for Adults Treated for Ewing Sarcoma. Cancer Management and Research. Volume 15. 537–545. 1 indexed citations
9.
Boughdad, Sarah, Naïk Vietti Violi, Antonia Digklia, et al.. (2023). Imaging assessment of toxicity related to immune checkpoint inhibitors. Frontiers in Immunology. 14. 1133207–1133207. 7 indexed citations
10.
Tsoumakidou, Georgia, et al.. (2022). Case Report: Tyrosine Kinase Inhibitors Induced Lymphadenopathy in Desmoid Tumor Patients. Frontiers in Endocrinology. 13. 794512–794512. 3 indexed citations
11.
Mathevet, Patrice, Martin Hübner, Nicolas C. Buchs, et al.. (2022). Traitements intrapéritonéaux de la carcinose ovarienne : proposition d’algorithmes décisionnels. Revue Médicale Suisse. 18(782). 990–996. 1 indexed citations
12.
Zingg, Tobias, Antonia Digklia, Fabio Becce, et al.. (2021). [Management of abdominal soft tissue sarcomas].. PubMed. 17(743). 1172–1176. 2 indexed citations
14.
Denys, Alban, Olivier Séror, Naïk Vietti Violi, et al.. (2018). Hepatocellular carcinoma abutting large vessels: comparison of four percutaneous ablation systems. International Journal of Hyperthermia. 34(8). 1171–1178. 23 indexed citations
15.
Digklia, Antonia, Rafael Durán, Krisztián Homicskó, et al.. (2018). Cancer Immunotherapy: A Simple Guide for Interventional Radiologists of New Therapeutic Approaches. CardioVascular and Interventional Radiology. 42(9). 1221–1229. 3 indexed citations
16.
Durán, Rafael, et al.. (2017). [Treatment of advanced hepatocellular carcinoma : Novel agents and role of local therapy].. PubMed. 13(563). 1032–1034. 2 indexed citations
17.
Panos, Georgios D., Leonidas D Panos, Antonia Digklia, Farhad Hafezi, & Zisis Gatzioufas. (2014). Unusual Presentation of Cerebral Venous Sinus Thrombosis Associated with Contraceptive Usage. SHILAP Revista de lepidopterología. 2 indexed citations
18.
Digklia, Antonia. (2013). Targeted treatments for metastatic esophageal squamous cell cancer. World Journal of Gastrointestinal Oncology. 5(5). 88–88. 7 indexed citations
19.
Digklia, Antonia, et al.. (2013). Cutaneous leukocytoclastic vasculitis associated with letrozole. Journal of Oncology Pharmacy Practice. 20(2). 146–148. 8 indexed citations
20.
Digklia, Antonia & Ioannis A. Voutsadakis. (2012). Acute Cerebrovascular Accident after Cisplatin Treatment in a Patient Taking Letrozole. Chemotherapy. 58(6). 435–438. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026